US 12,214,177 B2
Flexible modules for injection devices
Dietmar Hammen, Frankfurt am Main (DE); and Thomas Klemm, Frankfurt am Main (DE)
Assigned to Sanofi-Aventis Deutschland GMBH, Frankfurt am Main (DE)
Filed by Sanofi-Aventis Deutschland GmbH, Frankfurt am Main (DE)
Filed on Jul. 25, 2022, as Appl. No. 17/872,795.
Application 17/872,795 is a continuation of application No. 16/480,840, granted, now 11,524,122, previously published as PCT/EP2018/051811, filed on Jan. 25, 2018.
Claims priority of application No. 17153398 (EP), filed on Jan. 26, 2017.
Prior Publication US 2023/0011040 A1, Jan. 12, 2023
Int. Cl. A61M 5/315 (2006.01); A61M 5/24 (2006.01); A61M 5/31 (2006.01)
CPC A61M 5/31593 (2013.01) [A61M 5/24 (2013.01); A61M 5/31585 (2013.01); A61M 2005/3126 (2013.01); A61M 5/31525 (2013.01); A61M 5/31568 (2013.01); A61M 2205/50 (2013.01); A61M 2205/58 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method of operating a module associated with an auto injector, the method comprising:
determining that the module is in a near-field communication (NFC) region;
in response to the determining, retrieving, from a memory of the module, data associated with a medicament contained in the auto injector, the medicament comprising antibodies selected from the group consisting of: anti PCSK-9, anti IL-6 mAb, and anti IL-4 mAb; and
transmitting the data associated with the medicament from an antenna of the module to an external device in the NFC region,
wherein the module is configured to attach to the auto injector through an adhesive layer of the module.